publication venue for
- Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia.. 8. 2024
- Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party.. 6. 2021
- A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma.. 5. 2021
- Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies.. 5. 2021
- Bone marrow niche in multiple myeloma and its precursor states.. 3. 2019
- LSD1 Inhibition Prolongs Survival in Mouse Models of MPN by Selectively Targeting the Disease Clone.. 2. 2018
- Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia.. 2. 2018
- Untreated Anemia in Nontransfusion-dependent β-thalassemia: Time to Sound the Alarm.. 6. 2022
- A Question of Frame: The Role of the Bone Marrow Stromal Niche in Myeloid Malignancies. 2023